Skip to main content

Haemophilus B Conjugate (Prp-Omp) Vaccine Dosage

Medically reviewed by Last updated on Nov 30, 2020.

Applies to the following strengths: 7.5 mcg-125 mcg/0.5 mL

Usual Pediatric Dose for Haemophilus influenzae Prophylaxis

2 to 14 months of age: Two 0.5 mL doses intramuscularly two months apart
-Children who get their first dose of this vaccine between 2 and 10 months of age should get a booster vaccination at 12 to 15 months of age.

15 to 71 months of age, previously unvaccinated: 0.5 mL intramuscularly once

-Use is not recommended in infants younger than 6 weeks of age due to the potential for immune tolerance.
-This product may be interchanged with other licensed Haemophilus b (Hib) Conjugate Vaccines for primary and booster vaccination.
-A booster dose is required for infants that complete the regimen before 12 months of age; this maintains antibody levels during the first 2 years of life when the risk of invasive Hib is highest.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available


-Hypersensitivity to any of the ingredients
-If hypersensitivity symptoms develop after injection, do not give further injections of this vaccine

Safety and efficacy have not been established in patients younger than 2 months or older than 71 months.

To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at:

Consult WARNINGS section for additional precautions.


Data not available

Other Comments

Administration advice:
-For intramuscular use; do not administer intravenously

Storage requirements: Refrigerate; do not freeze

More about haemophilus b conjugate (prp-omp) vaccine

Consumer resources

Other brands
Liquid PedvaxHIB

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.